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Summary 
Rationale, aims and objectives: The practice of glycaemic control of critically ill patients 
admitted to intensive care units (ICUs) is guided by clinical management protocols, designed 
locally by the ICUs. These protocols differ significantly in their aims and methods. The aim 
of this study was to develop a standardised methodology for the systematic and objective 
analysis and comparison of protocols for glycaemic control implemented in any ICU. 
Method: The protocols for glycaemic control implemented in seven ICUs of a UK-based 
ICU network were analysed using techniques of inductive content analysis, through an open 
coding process and the framework method. This involved the identification and classification 
of protocol instructions for glycaemic control, as well as of the processes and decisions 
pertaining to each of these instructions. These were used to develop a framework for the 
structured and systematic description and comparison of the protocols’ contents, and to 
develop a technique for the protocols’ graphic visualisation. Results: The following elements 
were identified or developed: (a) 35 quantifiable variables and 11 non-quantifiable subjects 
that could be present in an ICU protocol for glycaemic control, to be used as a framework for 
the description and comparison of contents; (b) a technique for condensing a protocol into a 
single, comprehensive flowchart; (c) using these flowcharts, a method for assessing the 
complexity and comprehensiveness of the protocols. Conclusions: The methodology 
developed in this study will allow for any future work analysing the contents of glycaemic 
control protocols to be carried out in a structured and standardised way. This may be done 
either as a standalone study, or as the essential first step in any investigation on the impact of 
new protocols. In turn, the methodology will facilitate the performance of regional, national 
and international comparisons, demonstrating the usefulness of this study at a global scale. 
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Introduction 
Hyperglycaemia, hypoglycaemia and increased glycaemic variability are three domains of 
glycaemic control that have been associated with higher risks of poor outcomes in critically 
ill patients, including impaired wound healing, neuro-myopathy, sepsis, multiple organ 
failure, cardiac dysfunction and mortality [1]. Currently, available evidence about ideal 
glycaemic target ranges, and the safest and most effective methods of glycaemic control to 
achieve these in intensive care units (ICUs), is discrepant and conflicting [2–6]. This is a 
crucial barrier to the development of common quality standards for glycaemic control of the 
critically ill. Thus, the recommendations of existing national and international guidelines on 
glycaemic control in the ICU differ among each other [7–18].  
As a consequence of the discrepant evidence and the lack of common guidelines and 
standards about the management of dysglycaemias in intensive care, ICUs implement their 
own locally developed clinical management protocols for glycaemic control [19–25]. Clinical 
management protocols have been defined as documents that “provide advice to decide about 
what clinical diagnostic and treatment steps should be taken (…)”, including “(…) documents 
relating only to drug doses and prescription timing for the treatment of specific medical 
conditions” [26]. For ease of reading, these will be referred to as protocols.  
 Numerous studies have been carried out comparing the effectiveness of local protocols for 
glycaemic control [27–30], but these studies usually lack the fundamental previous step of 
describing and comparing in detail the characteristics and instructions of the protocols under 
comparison. The few reported studies describing and comparing different protocols for 
glycaemic control found important variances between them [20,23]. However, these studies 
either dealt with general descriptions of the protocols’ instructions, or they focused mainly on 
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the protocols’ insulin algorithms. There is a lack of studies that report detailed descriptions 
and comparisons of each of the protocols’ instructions for the management of different 
glycaemic ranges. This is possibly due to the lack of a standardised, replicable and globally 
transferable method, that allows for systematic descriptions and comparisons of the contents 
of ICU protocols for glycaemic control, and which would make these analyses 
comprehensive and comparable across hospitals and internationally.  
The aim of this study was to develop a specific methodology for the systematic quantitative 
and qualitative description and comparison of the contents of protocols for glycaemic control. 
The aim was for this methodology to be comprehensive, as well as flexible, so that it could be 
used in any future studies requiring or aiming to describe and compare such protocols. This 
was part of a larger study, known as GlyCon, carried out within seven ICUs of the Mid Trent 
Critical Care Network (MTCCN). 
Methods 
Sample of protocols 
The MTCCN is a critical care network of ICUs in the UK that aims to provide common 
standards of care and protocols to all critically ill patients admitted within the geographical 
area that it covers [31]. The MTCCN’s Service Improvement Group encourages and 
facilitates the sharing of local policies, procedures and guidelines among the staff of its ICUs 
[32], and accepted GlyCon  as a proposed study for the group. The seven ICUs of the 
MTCCN that admit patients with the highest levels of care needs (requiring either advanced 
respiratory support alone or support for a minimum of two organs), accepted to participate in 
GlyCon study. 
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Soft copies of the protocols for glycaemic control, which had been in place in the seven 
participating ICUs during the study period (2012-2013), were acquired from each of the units 
through the study’s local collaborators. In this study, the protocols for glycaemic control were 
the sources of information, whereas data were to be collected from the contents of these 
protocols.  
Data collection and analyses 
Data were collected (extracted from the protocols) through open coding (labelling) of the 
protocols’ content as described by Elo & Kyngäs [33]. This allowed categories of data to 
emerge directly from the textual information [34,35], i.e. to be inferred inductively. Through 
this procedure, codes (labels) were first assigned to the selected initial units of analysis. 
These were each of the text sentences, or clauses within sentences, written in the protocols. 
The codes were grouped into broader categories, and these codes and inferred categories were 
used to label subsequent units of analysis. Using the framework method [36], summarised 
data were included (charted) into a matrix of codes (columns) and protocols (rows). A final 
set of categories of data or subjects, which may be present in a protocol, was abstracted 
through systematic comparisons of the charted data across protocols. These were used to 
develop a framework to guide the description and comparison of the contents of protocols for 
glycaemic control. 
A technique for condensing protocol instructions within a single detailed flowchart, and a 
method for assessing the complexity and comprehensiveness of the protocols using such 
flowcharts, was proposed. Details about this technique are described in the results section, as 
this was a newly developed method and, therefore, an outcome of this study. For this method, 
a distinction was made between “processes”, “decisions” and “scenarios”. A process referred 
to any activity that should be carried out for the management of a patient’s glycaemic status. 
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A decision referred to any situation that would require thinking and judging what process 
should be carried out. For example, conditional instructions, such as “the insulin infusion 
may need to be modified after 12 hours if blood glucose levels are unstable”, involved a 
decision step. A scenario referred to a possible loop comprising a sequence of processes and 
decisions between one glycaemic measurement and the next.  
Ethical Considerations 
This study did not involve human subjects. The study had sponsorship from the University of 
Nottingham, and had the ethical approval from a UK NHS Research Ethics Committee (REC 
Reference number:14/EM/0177) and the Research and Development Department of the 
Research and Development Department of the Hospital Trust of each participating ICU. 
Results 
The outcomes of this study included: (a) the array of ‘categories’ that emerged from the 
analysis and, based on these, a list of quantifiable ‘variables’ (Table 1) and a list of non-
quantifiable ‘subjects’ (Table 2) that can be present in protocols for glycaemic control; (b) a 
technique for condensing a protocol into a single, comprehensive flowchart (Figure 1); (c) 
using the flowchart, a method for assessing the complexity and completeness of the protocols 
(Figure 2 and Table 3).  
Protocol categories, variables and subjects 
The two broadest categories of data identified in the protocols were: 
1) The method used for the protocol development. This category included metadata about 
when, how and by whom the protocol was developed, as well as the evidence on which 
the protocol was based, and for which target patients it was meant to be used. These could 
be either quantifiable characteristics or non-quantifiable features of the protocols. 
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2) The protocol instructions for glycaemic control. This category included any statement 
describing how glycaemic control should be carried out. Within this category, three key 
features were identified to classify each instruction:  
a) The aim of the instruction: Based on this feature, five ‘sub-categories’ were further 
identified, namely diagnostic, monitoring, treatment, organisational and mixed 
instructions. Diagnostic instructions referred to those instructions related to the 
definition of the glycaemic status of the patient. Monitoring instructions referred to 
any indications on how or when blood glucose should be monitored. Treatment 
instructions included any written directions on the administration of insulin, other 
medication or glucose solutions with the aim of affecting glycaemic levels. 
Organisational instructions were indications related to the organisation of the ICU 
team, division of roles, or administrative activities, related to the management of 
glycaemic control in the ICU. Instructions that could be classified in more than one 
category were considered as mixed type of instruction.  
b) The glycaemic status to which the instruction referred. Depending on this status, four 
further ‘sub-categories’ were distinguished, namely instructions relevant to glycaemic 
levels below, within or above the protocol’s glycaemic target range, as well as 
instructions that were relevant at all glycaemic levels.  
c) The quantifiable nature of the instruction. Based on this, instructions could be 
classified as either quantifiable data (instructions that could be counted or transformed 
into categorical variables) or non-quantifiable information.  
These categories of protocol instructions were used to create the list of quantifiable variables 
(Table 1, 35 variables in total) and the list of non-quantifiable subjects (Table 2, 11 subjects 
in total). 
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Protocol flowcharts and scenarios 
The proposed method to design protocol flowcharts, and describe them, includes the steps 
enumerated below. An example of how this would be done is illustrated in Figure 1 and 
Figure 2. 
1) Identify each of the glycaemic ranges considered by the protocol. 
2) Identify all the instructions dealing with each of these glycaemic ranges, for any given 
glycaemic measurement, and classify them as either a process or a decision (as defined in 
the Methods section).  
3) Depict these processes and decisions schematically in closed-loop flowcharts, in a way 
that each loop (scenario) starts and finishes with a glycaemic measurement (Figure 1 and 
Figure 2). Processes should be represented with a rectangle, decisions with a diamond, 
and outputs or data (such as glycaemic levels) with a parallelogram, following the 
International Organization for Standardization (ISO) 5807 norm  [37]. An example of the 
resulting flowchart for one of the protocols included in GlyCon study is included in 
Figure 1. 
4) Identify and count all glycaemic ranges considered by the flowchart.  
5) Identify and count all scenarios considered by the flowchart.  
6) Identify and count all processes and decisions proposed within each scenario.  
7) Populate Table 3 with metrics about the above counts (totals, medians and ranges), and 
with the types of processes and decisions considered by the flowcharts. 
The metrics in Table 3 can be used to describe the number and types of scenarios, and 
processes and decisions interacting within each scenario. This may then be used to compare 
the complexity and comprehensiveness of different protocols for glycaemic control. Data 
from Table 1 and Table 2 complement Table 3 for such descriptions. In this respect, it is 
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useful to note that Grol et al. [38] described an instruction or recommendation as complex 
when it is composed of numerous different interacting elements, and includes a complex 
decision tree, besides other factors that could affect these elements. 
Discussion 
Current management of stress hyperglycaemia among ICUs varies across ICUs globally, as 
well as among ICUs within the same country [21,22]. We have developed a convenient and 
comprehensive methodology to facilitate the structured and systematic investigation of 
recommendations and instructions within clinical management protocols for glycaemic 
control in the ICU. 
At present there are a number of guideline appraisal tools that aim to help in assessing the 
quality of guidelines [39]. These tools are generic instruments that assess whether guidelines 
follow the principles of evidence based medicine, their aims and methods of development, 
and their clarity and applicability. Amongst the most widely used tools is the Appraisal of 
Guidelines for Research & Evaluation (AGREE) II instrument, which was developed to 
assess the quality of clinical guidelines, and whether they should be recommended for use in 
practice [40]. This instrument rates the level to which guidelines deal with relevant aspects 
including their scope and purpose, stakeholder involvement, rigour of development, clarity of 
presentation, applicability and editorial independence. The iCAHE Guideline Quality 
Checklist [41] was developed  as a shorter alternative to the AGREE II instrument. However, 
as it has been noted in previous studies [26], these tools are not relevant to studies exploring 
specific content recommendations or specific instructions within guidelines. They do not 
provide a structured methodology for the thorough description and comparison of the 
contents and complexity of the specific instructions of a protocol, which was the aim of our 
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study.  Specifically, we aimed to develop a methodology for identifying, describing and 
comparing each of the specific instructions included in the clinical management protocols for 
glycaemic control of any ICU. 
The methodology used in this study has important strengths which can be summarised as 
follows. The combination of techniques of inductive content analysis and the framework 
method led to the systematic identification of a well-structured set of categories of 
instructions for glycaemic control, which had not been identified before. In the proposed 
framework for the analysis of protocols, a number of non-quantifiable subjects were included 
with the aims not only of enriching the quantifiable summaries, but also to help in 
understanding the rationale for the instructions and other types of data that cannot be 
quantified, as well as to make the findings more context specific. Separating these 
instructions according to the glycaemic status, rather than by narrower glycaemic ranges, as 
well as according to the recommendation type, provided a framework within which the 
instructions of different protocols for glycaemic control can be fitted and compared. This 
makes the method universally applicable to the analysis of different protocols. The proposed 
method to represent and summarise protocols graphically, through flow charts, provides a 
visual representation of the events sequence, which helps gain a shared understanding of the 
processes and decisions involved in the management of all and each of the glycaemic ranges 
considered by each protocol. The visual representation also helps to easily describe and 
compare the complexity and completeness of the protocols. 
Therefore, the set of tools developed in GlyCon will facilitate the performance of future 
stuides exploring the practice of glycaemic control in ICU, and will increase the 
comparability and transferability of such studies. These studies are crucial to enable 
clinicians and researchers have a better understanding about how dysglycaemias in the 
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critically ill are currently being managed within the ICU, whether at the institutional, regional 
or international levels. Moreover, exploring the recommendations that guide the methods for 
glycaemic control implemented in the ICU should be an essential first step of any study 
looking at the impact of such methods, including their effectiveness, efficiency and safety. 
Conclusions: 
Future work analysing and comparing the contents of local protocols for glycaemic control in 
ICU is essential to enable the clinical and scientific communities understand how 
dysglycaemic events are currently being managed in intensive care. Furthermore, these 
studies should be a fundamental initial step of any impact (outcome) evaluation of these 
protocols. The proposed methodology, developed as part of GlyCon study, will allow for 
such future work to be carried out in a standardised and comparable way. In turn, this will 
facilitate the performance of national and international comparisons, demonstrating the 
usefulness of this study at a global scale.  
  
12 
 
 
Acknowledgements 
We would like to thank all local collaborators of GlyCon study in each of the participating 
ICUs, for sharing their local protocols and policies. We would like to thank the Mid Trent 
Critical Care Network, for endorsing GlyCon as a study of their Quality Improvement Group. 
This work was supported by Nottingham University Hospitals (NUH) Charity and the NUH 
Department of Research and Innovation (grant awarded to Dr Gary Adams), and the 
University of Nottingham School of Health Sciences director of research small grants. The 
funding body did not participate in the design of the study and collection, analysis, and 
interpretation of data or in writing the manuscript. 
References 
1.  Krinsley JS. Understanding glycemic control in the critically ill: three domains are better 
than one. Intensive Care Med. 2011;37(3):382-384. doi:10.1007/s00134-010-2110-3 
2.  Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill 
patients. N Engl J Med. 2001;345(19):1359-1367. doi:10.1056/NEJMoa011300 
3.  Chase G, Shaw GM, Le Compte A, et al. Implementation and evaluation of the SPRINT 
protocol for tight glycaemic control in critically ill patients: a clinical practice change. 
Crit Care. 2008;12(2):R49. doi:10.1186/cc6868 
4.  NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus 
conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-
1297. doi:10.1056/NEJMoa0810625 
5.  Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre 
controlled trial on tight glucose control by intensive insulin therapy in adult intensive 
13 
 
 
care units: the Glucontrol study. Intensive Care Med. 2009;35(10):1738-1748. 
doi:10.1007/s00134-009-1585-2 
6.  Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch 
resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-139. 
doi:10.1056/NEJMoa070716 
7.  Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international 
guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 
2013;39(2):165-228. doi:10.1007/s00134-012-2769-8 
8.  American Diabetes Association. Executive summary: Standards of medical care in 
diabetes--2012. Diabetes Care. 2014;37(Supplement_1):S4-S10. doi:10.2337/dc14-
S005 
9.  Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical 
Endocrinologists and American Diabetes Association consensus statement on inpatient 
glycemic control. Diabetes Care. 2009;32(6):1119-1131. doi:10.2337/dc09-9029 
10.  Australian Diabetes Society. Guidelines for Routine Glucose Control in Hospital. 
Australian Diabetes Society; 2012. 
11.  Australian Diabetes Society. Perioperative Diabetes Management Guidelines. Australian 
Diabetes Society; 2012. 
12.  SEMICYUC. Quality Indicators in Critically Ill Patients. Update 2011. Spanish Society 
of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and 
Enteral Nutrition; 2011. 
14 
 
 
13.  Ichai C, Preiser JC. International recommendations for glucose control in adult non 
diabetic critically ill patients. Crit Care. 2010;14(5):R166. doi:10.1186/cc9258 
14.  JBDS-IP. Glycaemic Management during the Inpatient Enteral Feeding of Stroke 
Patients with Diabetes Joint British Diabetes. Joint British Diabetes Societies (JBDS) 
for inpatient care Group; 2012. 
15.  JBDS-IP. Management of Adults with Diabetes Undergoing Surgery and Elective 
Procedures: Improving Standards. Joint British Diabetes Societies (JBDS) for inpatient 
care Group; 2011. 
16.  JBDS-IP. The Use of Variable Rate Intravenous Insulin Infusion (VRIII) in Medical 
Inpatients. Joint British Diabetes Societies (JBDS) for inpatient care Group; 2014. 
17.  Lü Q, Tong N. Interpretation of Chinese Society of Endocrinology consensus statement 
on hyperglycemia management target in adult inpatients in China (中华医学会内分泌
学分会《中国成人住院患者高血糖管理目标专家共识》解读). J Diabetes. 
2013;5(4):416-420. doi:10.1111/1753-0407.12058 
18.  Bruno G, De Micheli A, Frontoni S, Monge L. Highlights from “Italian Standards of Care 
for Diabetes Mellitus 2009-2010.” Nutr Metab Cardiovasc Dis. 2011;21(4):302-314. 
doi:10.1016/j.numecd.2010.08.009 
19.  Cook CB, Kongable GL, Potter DJ, Abad VJ, Leija DE, Anderson M. Inpatient glucose 
control: a glycemic survey of 126 U.S. hospitals. J Hosp Med. 2009;4(9):E7-E14. 
doi:10.1002/jhm.533 
15 
 
 
20.  Paddle JJ, Eve RL, Sharpe K a. Changing practice with changing research: results of two 
UK national surveys of intensive insulin therapy in intensive care patients. Anaesthesia. 
2011;66(2):92-96. doi:10.1111/j.1365-2044.2010.06603.x 
21.  Wilson M, Weinreb J, Soo Hoo GW, Hoo GWS. Intensive insulin therapy in critical care: 
a review of 12 protocols. Diabetes Care. 2007;30(4):1005-1011. doi:10.2337/dc06-1964 
22.  Tomlinson VH, Langley J, Meal AG, Adams GG. “Medioglycaemia”: A new concept in 
glycaemic control in intensive care (ICU) units? J Diabetes Mellit. 2012;2(4):361-368. 
doi:10.4236/jdm.2012.24056 
23.  Mackenzie I, Ingle S, Zaidi S, Buczaski S. Tight glycaemic control: a survey of intensive 
care practice in large English hospitals. Intensive Care Med. 2005;31(8):1136. 
doi:10.1007/s00134-005-2677-2 
24.  Orban J, Scarlatti A, Lefrant J, et al. Management of glycaemia: An audit in 66 ICUs 
[Gestion de la glycemie : un audit dans 66 reanimations]. Ann Fr Anesthèsie 
Rèanimation. 2013;32:84-88. doi:10.1016/j.annfar.2012.12.002 
25.  Niven DJ, Rubenfeld GD, Kramer AA, Stelfox HT. Effect of Published Scientific 
Evidence on Glycemic Control in Adult Intensive Care Units. JAMA Intern Med. 
2015;175(5):801. doi:10.1001/jamainternmed.2015.0157 
26.  Guo Y, Adelstein B-A, Rubin GL. Availability and development of guidelines in a 
tertiary teaching hospital. J Eval Clin Pract. 2007;13(4):632-638. doi:10.1111/j.1365-
2753.2007.00857.x 
16 
 
 
27.  Zimmerman CR, Mlynarek ME, Jordan J a, Rajda C a, Horst HM. An insulin infusion 
protocol in critically ill cardiothoracic surgery patients. Ann Pharmacother. 2004;38(7-
8):1123-1129. doi:10.1345/aph.1E018 
28.  Chant C, Mustard M, Thorpe KE, Friedrich JO. Nurse- vs Nomogram-Directed Glucose 
Control in a Cardiovascular Intensive Care Unit. Am J Crit Care. 2012;21(4):270-278. 
doi:10.4037/ajcc2012713 
29.  Scheuren L, Baetz B, Cawley MJ, Fitzpatrick R, Cachecho R. Pharmacist Designed and 
Nursing-driven Insulin Infusion Protocol to Achieve and Maintain Glycemic Control in 
Critical Care Patients. J Trauma Nurs. 2006;13(3):140-145. doi:10.1097/00043860-
200607000-00015 
30.  Kanji S, Jones E, Goddard R, Meggison HE, Neilipovitz D. Efficiency and safety of a 
standardized protocol for intravenous insulin therapy in ICU patients with neurovascular 
or head injury. Neurocrit Care. 2010;12(1):43-49. doi:10.1007/s12028-009-9275-z 
31.  UK Department of Health. Comprehensive Critical Care. A Review of Adult Critical 
Care Services. London, UK; 2000. 
32.  Mid Trent Critical Care Network. Mid Trent Critical Care Network. Home. 
http://www.midtrentccn.nhs.uk/. Published 2011. 
33.  Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107-
115. doi:10.1111/j.1365-2648.2007.04569.x 
34.  Hsieh HF, Shannon SE. Three Approaches to Qualitative Content Analysis. Qual Health 
Res. 2005;15(9):1277-1288. doi:10.1177/1049732305276687 
17 
 
 
35.  Phil J. Inductive Analysis. In: Thorpe R, Holt R, eds. The SAGE Dictionary of Qualitative 
Management Research. London: SAGE Publications Ltd; 2008:298-299. 
doi:10.4135/9780857020109 
36.  Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for 
the analysis of qualitative\ndata in multi-disciplinary health research. BMC Med Res 
Methodol. 2013;13:117. 
37.  ISO. ISO 5807: Information Processing—document Symbols and Conventions for Data, 
Program and System Flowcharts, Program Network Charts and System Resource 
Charts. Geneva; 1985. 
38.  Grol R, Dalhuijsen J, Thomas S, Rutten G, Mokkink H. Attributes of clinical guidelines 
that influence use of guidelines in general practice: observational study. Br Med J. 
1998;317:858-861. 
39.  Siering U, Eikermann M, Hausner E, Hoffmann-eßer W, Neugebauer EA. Appraisal 
Tools for Clinical Practice Guidelines : A Systematic Review. PloS One. 2013;8(12). 
doi:10.1371/journal.pone.0082915 
40.  Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline 
development, reporting and evaluation in health care. Can Med Assoc J. 
2010;182(18):E839-E842. doi:10.1503/cmaj.090449 
41.  Grimmer K, Dizon J, Milanese S, et al. Efficient clinical evaluation of guideline quality: 
development and testing of a new tool. BMC Med Res Methodol. 2014;14(1):63. 
doi:10.1186/1471-2288-14-63 
18 
 
 
 
Figure 1 – Example of one of the resulting flowcharts of protocol instructions. BG: blood 
glucose; IU: international units of insulin; h: hour 
 
Figure 2 – Example of the scenario analysis of protocol flowcharts. Left: identification of one 
possible scenario (loop) from one glycaemic measurement within 4.0-6.1mmol/L and the next 
glycaemic measurement. Right: identification of the numbers and types of processes and 
decisions within one scenario. BG: blood glucose; IU: international units of insulin; h: hour 
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Table 1 - Quantifiable variables that could be present in protocols for glycaemic control, organised by 
instruction aim & glycaemic status to which the instruction is relevant - template table for future studies. 
Glycaemic 
Status 
Instr. 
Aim* Quantifiable Variables 
Protocol ID 
1[j] 2 Etc. 
W
IT
H
IN
 
gl
yc
ae
m
ic
 
ta
rg
et
 
D Upper limit of glycaemic target range … … … 
D Lower limit of glycaemic target range  … … … 
M Minimum recommended time to next measurement (TNM)  … … … 
M Maximum recommended TNM … … … 
T Minimum recommended intravenous (IV) insulin infusion rate (IIR) [a]  … … … 
T Maximum recommended IV IIR  … … … 
A
BO
V
E 
gl
yc
ae
m
ic
 
ta
rg
et
 
O Is there a hyperglycaemic threshold instructing to inform medical staff? … … … 
D,O Hyperglycaemic threshold indicating when to inform medical staff … … … 
M Minimum recommended TNM (h)  … … … 
M Maximum recommended TNM (h)  … … … 
T Minimum recommended IV IIR (U/h)  … … … 
T Maximum recommended IV IIR  … … … 
B
E
L
O
W
 g
ly
ca
em
ic
 
ta
rg
et
 
O Is there a hypoglycaemic threshold instructing to inform medical staff? … … … 
D,O Hypoglycaemic threshold indicating when to inform medical staff … … … 
D,T Hypoglycaemic threshold indicating rescue glucose always … … … 
M Minimum recommended TNM if severe hypoglycaemia (h) [b] … … … 
M Maximum recommended TNM if severe hypoglycaemia (h) … … … 
T Minimum recommended IV IIR if severe hypoglycaemia (U/h)  … … … 
T Maximum recommended IV IIR if severe hypoglycaemia (U/h) … … … 
T Minimum recommended IV glucose if severe hypoglycaemia (grams, g) … … … 
T Maximum recommended IV glucose if severe hypoglycaemia (g) … … … 
G
E
N
E
R
A
L 
 in
st
ru
ct
io
ns
 
at
 a
ny
 g
ly
ca
em
ic
 le
ve
l  D,T Glycaemic threshold determining start of insulin infusion … … … 
M Preferred monitoring method [c] … … … 
M Preferred monitoring blood sample [d] … … … 
T Preferred insulin type [e] … … … 
T Preferred insulin administration route [f] … … … 
T Insulin titration method during admission [g] … … … 
T Treatment actions depending on underlying condition or severity [h] … … … 
T Treatment actions depending on concomitant medication[h] … … … 
T Treatment actions if no feeding/glucose-based maintenance fluid … … … 
O Is management after ICU discharge mentioned? … … … 
D
EV
EL
O
P-
M
EN
T 
ch
ar
ac
te
ri
st
ic
s P Are protocol development methods mentioned? … … … 
P Are protocol developers mentioned? … … … 
P Is protocol evidence base mentioned? … … … 
P Launch date / date of last update … … … 
  … … … 
* Instruction aim codes legend: 
D:     Diagnostic instructions 
M:    Monitoring instructions 
T:     Treatment instructions 
O:    Organisational instructions 
P:     Protocol development characteristics 
  
 
[a]   All insulin infusion rates of IV fast acting insulin in International Units per hour (U/h) 
[b]   Severe hypoglycaemia defined as random blood glucose ≤2.2 mmol/L or symptomatic hypoglycaemia 
[c]   Blood Gas Analyser / Glucose Meter  / Laboratory /  Not Mentioned 
[d]   Arterial / Venous / Capillary / Not Mentioned 
[e]   Fast-acting  / Fast-acting + Basal / Not mentioned 
[f]    Intravenous / Subcutaneous  / Both intravenous and subcutaneous accepted  / Not mentioned   
[g]   Fixed rates / Adjustments of previous rates  
[h]   Different IIR / Different TNM/ Mentioned as an aspect that should be considered / Not mentioned   
[j]   Data included as numbers, with one value per cell (i.e. per variable and protocol), representing either a 
numerical variable or the numerical code assigned to a categorical variable 
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Table 2 – Non-quantifiable ‘subjects’ that could be present in protocols for glycaemic control, 
organised by instruction aim. Template table for future studies. 
Instr. 
Aim* Non-quantifiable information – subjects (data included as text in each cell) 
Protocol ID 
  1[a] 2 Etc. 
P Target patients … … … 
P Evidence base supporting the protocol instructions … … … 
P Development methods … … … 
T Recommended insulin/s … … … 
T Rationale for adjusting insulin infusion rates (IIR) on admission … … … 
T Rationale for adjusting IIR during admission … … … 
T Instructions on feeding management … … … 
M Rationale for adjusting the times to next meausrement (TNMs) on admission … … … 
M Rationale for adjusting TNMs during admission … … … 
D,M,T Differences in diagnostic, monitoring and treatment instructions in patients with diabetes … … … 
D,M,T Diagnosis, monitoring and treatment of “severe” and “moderate” hypoglycaemia … … … 
     
* Instruction aim codes legend: 
D:     Diagnostic instructions 
M:    Monitoring instructions 
P:     Protocol development characteristics  
T:     Treatment instructions 
 
[a] Data included as text in each cell (i.e., in each subject for each protocol) 
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Table 3 – Numbers (total, median and range) and types of scenarios, processes and decisions included in 
the protocol/s for glycaemic control. Template table for future studies. 
 
Protocol ID 
  1   2   Etc. 
Total number of scenarios per protocol … … … 
Median (range) number of processes per scenario  … … … 
Median (range) number of decisions per scenario  … … … 
Total number of glycaemic ranges considered per protocol … … … 
Are there any processes related to the following? (answer yes/no) 
   
Glycaemic monitoring frequency  … … … 
Glycaemic monitoring methods (device/blood sample)  … … … 
Insulin infusion rates  … … … 
Insulin administration route  … … … 
Rescue glucose infusion rates  … … … 
Feeding assessment  … … … 
Feeding rates  … … … 
Calling medical staff / prescriber  … … … 
Contacting diabetes team  … … … 
Identifying cause of hypoglycaemia  … … … 
Checking urine ketones  … … … 
Considering patients’ underlying condition or severity … … … 
Other [other fields can be added if needed] … … … 
Are there any decisions related to the following? (answer yes/no) 
   
Glycaemic monitoring frequency  … … … 
Glycaemic monitoring methods (device/blood sample)  … … … 
Insulin infusion rates  … … … 
Insulin administration route  … … … 
Rescue glucose infusion rates  … … … 
Feeding assessment  … … … 
Feeding rates  … … … 
Calling medical staff / prescriber  … … … 
Contacting diabetes team  … … … 
Identifying cause of hypoglycaemia  … … … 
Checking urine ketones  … … … 
Considering patients’ underlying condition or severity … … … 
Other [other fields can be added if needed] … … … 
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Figure 1 
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Figure 2 
 
